ストックスクリーナーアプリを入手
18.61
1.06%
-0.20
前日終値:
$18.81
開ける：
$18.25
24時間の取引高:
1.03M
Relative Volume:
0.54
時価総額：
$1.27B
収益：
$1.01B
当期純損益:
$-204.71M
株価収益率:
-6.0637
EPS:
-3.0691
ネットキャッシュフロー:
$-29.67M
1週間 パフォーマンス:
-20.20%
1か月 パフォーマンス:
-26.24%
6か月 パフォーマンス:
+41.95%
1年 パフォーマンス:
-1.48%
1日の値動き範囲:
$18.08
$19.09
1週間の範囲:
$18.08
$22.97
52週間の値動き範囲:
$9.98
$29.65
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
名前
Tandem Diabetes Care Inc
セクター
電話
858-366-6900
住所
12400 HIGH BLUFF DRIVE, San Diego, CA
Compare TNDM vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
18.61 | 1.29B | 1.01B | -204.71M | -29.67M | -3.0691 |
ABT
Abbott Laboratories
|
102.87 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
331.54 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.63 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.82 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.05 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-19 | アップグレード | Truist | Hold → Buy |
| 2026-03-17 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2026-02-23 | アップグレード | Lake Street | Hold → Buy |
| 2026-02-20 | アップグレード | BofA Securities | Underperform → Neutral |
| 2026-01-27 | 再開されました | TD Cowen | Buy |
| 2025-12-16 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2025-10-21 | 再開されました | Stifel | Hold |
| 2025-09-08 | 開始されました | Oppenheimer | Outperform |
| 2025-08-12 | アップグレード | Citigroup | Sell → Neutral |
| 2025-08-07 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2025-07-09 | ダウングレード | Citigroup | Neutral → Sell |
| 2025-06-16 | 開始されました | Truist | Hold |
| 2025-04-10 | 開始されました | Mizuho | Neutral |
| 2025-03-05 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-04 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-03-03 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2025-02-28 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2024-12-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | 開始されました | Bernstein | Outperform |
| 2024-10-04 | 開始されました | Goldman | Neutral |
| 2024-10-02 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-08-22 | 開始されました | Morgan Stanley | Equal-Weight |
| 2024-08-08 | 開始されました | Canaccord Genuity | Buy |
| 2024-05-30 | 開始されました | Redburn Atlantic | Buy |
| 2024-05-22 | アップグレード | Citigroup | Neutral → Buy |
| 2024-04-29 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | アップグレード | Stifel | Hold → Buy |
| 2023-08-04 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-05-05 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-04-24 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | 開始されました | UBS | Neutral |
| 2023-01-26 | 開始されました | Wolfe Research | Peer Perform |
| 2022-11-15 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-08-09 | ダウングレード | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | 再開されました | BofA Securities | Neutral |
| 2022-01-19 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | 再開されました | Cowen | Outperform |
| 2021-05-25 | 開始されました | Barclays | Underweight |
| 2020-12-15 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | 開始されました | Wells Fargo | Overweight |
| 2020-07-31 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-07-06 | アップグレード | Citigroup | Neutral → Buy |
| 2020-06-18 | 繰り返されました | Raymond James | Outperform |
| 2020-04-24 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | ダウングレード | Guggenheim | Buy → Neutral |
| 2020-03-05 | 開始されました | Citigroup | Neutral |
| 2020-02-06 | 開始されました | Raymond James | Outperform |
| 2020-02-04 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | 開始されました | Guggenheim | Buy |
| 2019-10-04 | アップグレード | UBS | Neutral → Buy |
| 2019-05-17 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-05-13 | 開始されました | SVB Leerink | Outperform |
| 2019-03-08 | 開始されました | BMO Capital Markets | Outperform |
| 2019-03-05 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-02-27 | 繰り返されました | Lake Street | Buy |
| 2018-11-21 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | 繰り返されました | Dougherty & Company | Buy |
| 2018-09-26 | 繰り返されました | Piper Jaffray | Overweight |
すべてを表示
Tandem Diabetes Care Inc (TNDM) 最新ニュース
Tandem Diabetes Care to Announce Q1 2026 Results on May 7 - National Today
Tandem Diabetes Care to Announce First Quarter 2026 Financial Results on May 7, 2026 - businesswire.com
Tandem Diabetes Care (TNDM) reports Q4 earnings: What key metrics have to say - MSN
Diabetes Focused MiniMed Recovery Story Builds As Pipeline ImprovesMinimed Group (NASDAQ:MMED) - Benzinga
Earnings Report: Should value investors consider Tandem Diabetes Care Inc2026 Top Decliners & Fast Momentum Entry Tips - baoquankhu1.vn
Tandem Diabetes Care Stock Hits Day Low Amid Price Pressure at $20.93 - Markets Mojo
Stock List: Research Stocks from Around the World - GuruFocus
Tandem Diabetes and Roche Reach a Patent Settlement - MSN
Board asks shareholders to approve 3.26M-share increase; TNDM files proxy (TNDM) - Stock Titan
Tandem Diabetes Care (NASDAQ:TNDM) Trading Down 6.6%Time to Sell? - MarketBeat
Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know - TradingView
[SCHEDULE 13G/A] TANDEM DIABETES CARE INC Amended Passive Investment Disclosure - Stock Titan
Tandem Diabetes Care, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
Mizuho maintains Tandem Diabetes Care (TNDM) neutral recommendation - MSN
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Assenagon Asset Management S.A. Invests $26.99 Million in Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Strength seen in Tandem Diabetes Care (TNDM): Can its 9.1% jump turn into more strength? - msn.com
Tandem Diabetes Care, Inc. (TNDM) reports Q4 loss, tops revenue estimates - MSN
Tandem Diabetes Care Maps Pharmacy Shift, Targets 65% Gross Margin and 2026 Mobi Tubeless Launch - MarketBeat
Here’s why the Brown Capital Management Small Company Fund sold Tandem Diabetes Care (TNDM) - MSN
Reasons to hold Tandem Diabetes stock in your portfolio for now - MSN
US875372AE4 Latest News and Headlines - TradingView
US875372AE4 Bond Analysis — Key Metrics - TradingView
Tandem upgraded at Truist on pharmacy model (TNDM:NASDAQ) - Seeking Alpha
US875372AE4 Bond Price and Chart — FWB:US875372AE4 - TradingView
Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Up 5.3% on Analyst Upgrade - MarketBeat
Nvidia To $323? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga
This Union Pacific Analyst Turns Bullish; Here Are Top 3 Upgrades For Wednesday - Benzinga
Truist Financial Upgrades Tandem Diabetes Care (NASDAQ:TNDM) to "Buy" - MarketBeat
Tandem Diabetes Care analysts boost their forecasts after upbeat Q4 results - MSN
Tandem Diabetes (TNDM) Receives Upgrade Amid Revenue Growth Pros - GuruFocus
Tandem Diabetes (TNDM) EVP exercises 7,414 RSUs and sells 187 shares - Stock Titan
Lake Street upgrades Tandem Diabetes Care (TNDM) - MSN
Strength Seen in Tandem Diabetes Care (TNDM): Can Its 9.1% Jump Turn into More Strength? - Yahoo Finance
Piper Sandler upgrades Tandem Diabetes Care (TNDM) - MSN
Tandem Diabetes (TNDM) Stock Upgraded by Piper Sandler Amid Stra - GuruFocus
Piper Sandler Upgrades Tandem Diabetes Care (TNDM) to Overweight - GuruFocus
Tandem Diabetes Care (TNDM) insider files resale notice; 2 shares sold at $45.62 - Stock Titan
Tandem Diabetes Care Stock Upgrade & Market Outlook 2026News and Statistics - IndexBox
Why Are Tandem Diabetes (TNDM) Shares Soaring Today - Yahoo Finance
Bullish Call On Tandem Diabetes Signals Long-Term Growth Confidence - Benzinga
TNDM Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Tandem Diabetes Care (NASDAQ:TNDM) Shares Gap Up on Analyst Upgrade - MarketBeat
Tandem stock rises as Piper Sandler upgrades (TNDM:NASDAQ) - Seeking Alpha
Global Diabetes Care Devices Market to Accelerate Substantially at a CAGR of ~7% by 2034 | DelveInsight - PR Newswire
Tandem Diabetes Care (NASDAQ:TNDM) Upgraded at Piper Sandler - MarketBeat
Semtech To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
This Lemonade Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Benzinga
Tandem Diabetes Care Inc (TNDM) 財務データ
収益
当期純利益
現金流量
EPS
0.15%
大文字化:
|
ボリューム (24 時間):